Bristol-Myers Squibb
BMY
BMY
2,525 hedge funds and large institutions have $111B invested in Bristol-Myers Squibb in 2023 Q1 according to their latest regulatory filings, with 124 funds opening new positions, 1,048 increasing their positions, 1,007 reducing their positions, and 136 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,525
Holders Change
-63
Holders Change %
-2.43%
% of All Funds
40.41%
Holding in Top 10
68
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-9.33%
% of All Funds
1.09%
New
124
Increased
1,048
Reduced
1,007
Closed
136
Calls
$1.6B
Puts
$1.03B
Net Calls
+$568M
Net Calls Change
+$129M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$603M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$297M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$268M |
| 4 |
BlackRock
New York
|
+$198M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$169M |
